Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled dose-ranging study of H018 ointment in non-segmental vitiligo
CTR20254339Phase 2Active
- Sponsor
- 江苏柯菲平医药股份有限公司
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H018 ointment in Vitiligo, sponsored by 江苏柯菲平医药股份有限公司. Started Nov 2025; status: active.
02
Drugs
H018 ointment
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20254339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254339.